DENTSPLY SIRONA (NASDAQ:XRAY) Coverage Initiated by Analysts at Mizuho

Mizuho assumed coverage on shares of DENTSPLY SIRONA (NASDAQ:XRAY) in a research report sent to investors on Wednesday, MarketBeat Ratings reports. The brokerage issued a neutral rating and a $21.00 target price on the medical instruments supplier’s stock.

Several other research firms have also commented on XRAY. Needham & Company LLC lowered their price target on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a report on Friday, October 25th. Barrington Research lowered their price target on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating on the stock in a report on Friday, November 8th. StockNews.com lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Tuesday, November 19th. UBS Group lowered their target price on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating on the stock in a research note on Tuesday. Finally, Evercore ISI lowered their target price on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating on the stock in a research note on Tuesday, October 8th. Eight analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $28.40.

DENTSPLY SIRONA Price Performance

NASDAQ XRAY opened at $19.08 on Wednesday. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The stock’s fifty day moving average price is $21.86 and its 200 day moving average price is $24.49. DENTSPLY SIRONA has a 1 year low of $17.21 and a 1 year high of $37.60. The company has a market cap of $3.79 billion, a price-to-earnings ratio of -9.22, a PEG ratio of 1.91 and a beta of 0.96.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, beating the consensus estimate of $0.48 by $0.02. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The company had revenue of $951.00 million for the quarter, compared to analyst estimates of $939.10 million. During the same period in the prior year, the company earned $0.49 earnings per share. The firm’s revenue was up .4% on a year-over-year basis. As a group, equities research analysts forecast that DENTSPLY SIRONA will post 1.84 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the stock. UMB Bank n.a. lifted its stake in DENTSPLY SIRONA by 430.3% in the 3rd quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock valued at $25,000 after buying an additional 753 shares in the last quarter. Capital Performance Advisors LLP purchased a new position in DENTSPLY SIRONA in the 3rd quarter valued at about $27,000. LRI Investments LLC lifted its stake in DENTSPLY SIRONA by 82.7% in the 2nd quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock valued at $31,000 after buying an additional 564 shares in the last quarter. Kennebec Savings Bank purchased a new position in DENTSPLY SIRONA in the 3rd quarter valued at about $35,000. Finally, Rothschild Investment LLC purchased a new position in DENTSPLY SIRONA in the 2nd quarter valued at about $32,000. 95.70% of the stock is owned by hedge funds and other institutional investors.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.